— Know what they know.
Not Investment Advice

NSCIF OTC

Nanalysis Scientific Corp.
1W: -18.5% 1M: -3.9% 3M: -5.2% YTD: -39.8% 1Y: -41.0% 3Y: -78.3% 5Y: -91.0%
$0.08
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 42 · $11.3M mcap · 133M float · 0.0074% daily turnover · Short 55% of daily vol

Balance Sheet Trends

Total Assets
$42M -21.3% ▼
5Y CAGR: +18.3%
Total Liabilities
$27M -11.6% ▼
5Y CAGR: +53.1%
Shareholders Equity
$16M -33.8% ▼
5Y CAGR: +0.6%
Cash & Investments
$1M +81.3% ▲
5Y CAGR: -27.0%
Total Debt
$18M -16.4% ▼
5Y CAGR: +64.9%
Net Debt
$17M -19.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$3M$10M$4M$759K$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3M$10M$4M$759K$1M
Net Receivables$3M$6M$7M$10M$11M
Inventory$3M$4M$7M$6M$4M
Other Current Assets$1M$1M$2M$1M$1M
Total Current Assets$9M$21M$22M$18M$18M
Property, Plant & Equip.$2M$3M$6M$5M$3M
Goodwill & Intangibles$13M$14M$40M$9M$19M
Long-Term Investments$0$0$770K$6M$0
Other Non-Current Assets$0$0$939K$16M$2M
Total Non-Current Assets$15M$17M$48M$36M$24M
Total Assets$24M$38M$70M$54M$42M
— Liabilities —
Accounts Payable$3M$4M$6M$5M$6M
Short-Term Debt$209K$2M$4M$6M$6M
Deferred Revenue$2M$2M$2M$0$1M
Other Current Liabilities$774K$209K$1M$2M$517K
Total Current Liabilities$6M$9M$14M$15M$14M
Long-Term Debt$3M$3M$4M$13M$10M
Other Non-Current Liab.$668K$1M$2M$881K$158K
Total Non-Current Liabilities$4M$5M$9M$16M$12M
Total Liabilities$10M$14M$22M$30M$27M
— Equity —
Common Stock$21M$31M$49M$53M$58M
Retained Earnings-$8M-$10M-$19M-$35M-$49M
Accumulated OCI$215K$714K$969K$596K$430K
Total Stockholders Equity$14M$24M$35M$23M$16M
Total Liabilities & Equity$24M$38M$70M$54M$42M
— Key Metrics —
Total Debt$4M$6M$11M$22M$18M
Net Debt$618K-$4M$7M$21M$17M
Total Investments$0$0$770K$6M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms